货号:GS40623
Rontalizumab is a humanized monoclonal antibody targeting interferon-alpha (IFN-α). It binds to and neutralizes multiple subtypes of IFN-α, a key cytokine in the pathogenesis of systemic lupus erythematosus (SLE). It was developed to reduce disease activity by inhibiting IFN-α-mediated immune activation and inflammation in SLE patients with an elevated interferon signature.
武汉迈思生物科技有限公司
联系商家时请提及chemicalbook,有助于交易顺利完成!
迈思生物